Alterity Therapeutics Limited (ASX:ATH) Directors Insider Transactions
The Directors and Chief Executives of Alterity Therapeutics Limited (ASX:ATH) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Alterity Therapeutics Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Alterity Therapeutics Limited to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Alterity Therapeutics Limited Directors/Insider Transactions Activity
List of Insider trades activity from Alterity Therapeutics Limited (ATH).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 21 Nov 2025 | Kempler (Geoffrey Paul) | Former | 17,981,000 | - | - |
| 21 Nov 2025 | Meltzer (Brian Derek) | Former | 326,666 | - | - |
| 21 Nov 2025 | Stamler (David) | Chief Executive Officer | 76,444,800 | - | - |
| 30 Jun 2025 | Stamler (David) | Chief Executive Officer | 4,545,455 | - | - |
| 07 Apr 2025 | Gozlan (Lawrence) | Director (Non-Executive) | 4,545,455 | 29,545 | Other at price 0.01 per share. |
| 07 Apr 2025 | Marks (Peter Vincent) | Independent Non-Executive Director | 1,818,182 | 11,818 | Other at price 0.01 per share. |
| 07 Apr 2025 | Meltzer (Brian Derek) | Independent Non-Executive Director | 2,272,727 | 14,772 | Other at price 0.01 per share. |
| 30 Jun 2024 | Stamler (David) | Chief Executive Officer | 10,697,857 | - | - |